Syncona (SYNC) News Today → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free SYNC Stock Alerts GBX 121.82 -0.18 (-0.15%) (As of 04:27 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSyncona (LON:SYNC) Shares Pass Below Fifty Day Moving Average of $124.48americanbankingnews.com - May 4 at 6:10 AMLONDON BROKER RATINGS: Jefferies cuts AJ Bell; Deutsche likes ConvaTeclse.co.uk - May 3 at 4:39 AMSyncona agrees to sell stake in investee company for GBP7.4 millionlse.co.uk - April 11 at 12:50 PM4BIO Capital Portfolio Company Ascend Acquires Florida-Based GMP Manufacturing Capacitymarkets.businessinsider.com - April 9 at 1:05 PMOMass Therapeutics expands Scientific Advisory Board with the appointment of Sarah Teichmannmarkets.businessinsider.com - April 8 at 10:57 AMSyncona portfolio company Autolus posts widened loss for 2023lse.co.uk - March 14 at 10:41 AMFreeline Therapeutics Holdings plc: Acquisition of Freeline by Syncona Becomes Effectivefinanznachrichten.de - February 21 at 10:56 PMShortlist revealed for NED awardsthetimes.co.uk - February 10 at 11:29 PMBioNTech SE: BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programsfinanznachrichten.de - February 8 at 9:35 AMSyncona portfolio strengthens in third quarter thanks to Autoluslse.co.uk - February 8 at 9:35 AMUPDATE: Syncona portfolio strengthens thanks to Autoluslse.co.uk - February 8 at 9:35 AMSyncona says Freeline trial for Gaucher disease treatment positivelse.co.uk - January 19 at 9:37 AMSynconabbc.com - December 14 at 9:57 PMSyncona Portfolio Firm Beacon's AGTC-501 Trial Shows Positive Data In X-Linked Retinitis Pigmentosamarkets.businessinsider.com - December 4 at 9:08 AMBRIEF-Syncona Ltd To Acquire Freeline Therapeuticsmsn.com - November 23 at 9:01 AMFreeline Therapeutics Shares Rise on Takeover by Synconamarketwatch.com - November 22 at 2:01 PMGene Therapy Player Freeline Therapeutics Goes Private In $28M Dealmsn.com - November 22 at 2:01 PMFreeline Therapeutics Agrees to Buyout by Synconamarketwatch.com - November 22 at 9:00 AMFreeline Therapeutics To Be Bought By Syncona For $28.3 Mln In Cash; Freeline Stock Upmarkets.businessinsider.com - November 22 at 9:00 AMFreeline Therapeutics to be acquired by Syncona for $28.3M in cashmsn.com - November 22 at 9:00 AMSyncona to Acquire Freeline Therapeuticsfinance.yahoo.com - November 22 at 9:00 AMSyncona reports declining asset value as investment head steps downlse.co.uk - November 16 at 8:56 AMSyncona Proposes To Acquire Freeline Therapeuticsmarkets.businessinsider.com - October 18 at 12:52 PMFreeline gains on non-binding buyout offer from Synconamsn.com - October 18 at 12:52 PMSyncona Seeks to Buy Remaining Shares of Freeline Therapeuticsmarketwatch.com - October 18 at 7:33 AMSwanBio Evolves Leadership Team with Appointment of Executive Chair and Chief Operating Officerfinance.yahoo.com - October 16 at 7:59 AMSyncona Portfolio Company to Present Updated Data on Cancer Studymarketwatch.com - October 16 at 7:59 AMSwanBio Therapeutics: SwanBio Advances to Higher-Dose Cohort in First-in-Human Study of Gene Therapy for Adrenomyeloneuropathyfinanznachrichten.de - October 4 at 1:39 PMSwanBio Advances to Higher-Dose Cohort in First-in-Human Study of Gene Therapy for Adrenomyeloneuropathyfinance.yahoo.com - October 4 at 8:39 AMSyncona to Buy Back Up to GBP40 Mln in Sharesmarketwatch.com - September 29 at 10:39 AMForcefield Therapeutics appoints John Tsai MD as Chief Executive Officertmcnet.com - September 27 at 10:14 AMNovartis recalls Sandimmune oral solution due to crystal formationmsn.com - September 12 at 7:39 AMFTSE 250 movers: Vistry surges, Syncona sinks on write-offuk.investing.com - September 11 at 4:04 PMSyncona downcast as eye treatment is discontinuedthetimes.co.uk - September 11 at 4:04 PMUK's Syncona writes off 54.5 million stg after Novartis ends Gyroscope's therapyuk.finance.yahoo.com - September 11 at 9:37 AMSyncona suffers negative valuation hit as Novartis discontinues GT005lse.co.uk - September 11 at 9:37 AMUPDATE 1-UK Stocks-Factors to watch on Sept 11reuters.com - September 11 at 4:32 AMUK's Syncona writes off 54.5 mln stg after Novartis ends Gyroscope's therapyreuters.com - September 11 at 4:32 AMPurespring appoints Fredrik Erlandsson as Chief Medical Officer and Peter Mulcahy as Chief People Officermarkets.businessinsider.com - September 6 at 7:59 AMTruist Securities Maintains Autolus Therapeutics plc - ADR (AUTL) Buy Recommendationmsn.com - August 17 at 11:40 PMPurespring Therapeutics appoints Sachin Kelkar as Chief Financial Officer following appointment of Julian Hanak as Chief Executive Officerfinance.yahoo.com - August 2 at 8:34 AMOMass Therapeutics Expands Leadership Team with Two New Appointmentstechnews.tmcnet.com - August 2 at 3:34 AMSyncona is not in good shapethetimes.co.uk - June 15 at 8:15 PMSyncona Swung to FY 2023 Pretax Loss; To Deploy GBP150 Mln-GBP200 Mln in Capitalmarketwatch.com - June 15 at 10:15 AMBeacon Therapeutics launches with £96 million ($120 million)tmcnet.com - June 13 at 12:26 AMPharma giant AstraZeneca signs huge deal with UK start-up to create treatments for diabetes and other autoimmune diseasesmsn.com - June 9 at 9:16 PMTOP NEWS: AstraZeneca hails deal with Quell; positive danicopan datalse.co.uk - June 9 at 11:15 AMSYNC.L - Syncona Limitedfinance.yahoo.com - May 29 at 4:42 PMChardan Capital Maintains Achilles Therapeutics Plc - ADR (ACHL) Buy Recommendationmsn.com - May 12 at 7:27 PMOMass Therapeutics Announces New Phase of Growth with Move to New Facilities and Team Expansion to Support Portfolio Progressbenzinga.com - April 19 at 7:47 AM Get Syncona News Delivered to You Automatically Sign up to receive the latest news and ratings for SYNC and its competitors with MarketBeat's FREE daily newsletter. Email Address Exposed: 10 CENT Crypto to Explode May 20th? (Ad)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career… Click For My #1 FREE Crypto for 2024 SYNC Media Mentions By Week SYNC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SYNC News Sentiment▼0.490.56▲Average Financial Services News Sentiment SYNC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SYNC Articles This Week▼20▲SYNC Articles Average Week Get Syncona News Delivered to You Automatically Sign up to receive the latest news and ratings for SYNC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MRCH News Today ICGT News Today SDP News Today BBH News Today TFIF News Today NBPE News Today JFJ News Today SAIN News Today VOF News Today OTV2 News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:SYNC) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithDems have chosen Biden replacement?Paradigm Press348 million Americans lives to END as we know it?The Oxford ClubGold Set to EXPLODE!Gold Safe ExchangeHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syncona Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
